Title : Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment.

Pub. Date : 2020 Oct

PMID : 32763585






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 This study reports specifically on MCP-1 levels, as a potential marker of BDD and/or treatment response in patients receiving combination treatment with the cyclooxygenase-2 inhibitor, celecoxib (CBX). Celecoxib C-C motif chemokine ligand 2 Homo sapiens